You forgot to lol. If this is a shell, which it's not, what you say would be true. That is not true of epgl and here is why. 1. Shell companies do not have FDA approved devices. 2. Shell companies do not manufacture devices and release them for peer trial. 3. Shell companies do not have their debt replaced by PWc entirely with stock equity. I do not expect revenue numbers this month, buy by June we should be getting some solid numbers. Also, patent applications and products in the pipeline are essential fundementals for a medical device co. Those are the things that will keep restricted shares from being dumped whenever they become unrestricted, because the patents and pipeline increase the value and potential of the company.